Publications by authors named "M Melac"

Claim this Profile
C
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
L Mascarell, S Rak, M Worm, M Melac, S Soulie

Allergy· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.
Margitta Worm, Sabina Rak, Frédéric de Blay, Hans-Jorgen Malling, Michel Melac

Clin Transl Allergy· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
A Didier, H-J Malling, M Worm, F Horak, G Sussman, M Melac

Clin Exp Allergy· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
Linda S Cox, Thomas B Casale, Anjuli S Nayak, David I Bernstein, Peter S Creticos, Michel Melac

J Allergy Clin Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Alain Didier, Margitta Worm, Friedrich Horak, Gordon Sussman, Olivier de Beaumont, Michel Melac

J Allergy Clin Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis